Xconomy: Trimble Scoops Up ThingMagic, Resolvyx Sells Option to Celtic Therapeutics, GSK Venture Arm Puts $4M into Dicerna, & More Boston-Area Deals News
Summary
Trimble Scoops Up ThingMagic, Resolvyx Sells Option to Celtic Therapeutics, GSK Venture Arm Puts $4M into Dicerna, & More Boston-Area Deals News Xconomy Boston — Dealmaking activity was on the light side this week in the New England tech and life sciences sectors, but there are still some interesting items to report.The Boston-based startup is taking a local-search approach to helping people find events and activities.Founded in 2007, Dicerna competes with the likes of Cambridge, MA-based Alnylam Pharmaceuticals (NASDAQ:ALNM) in developing drugs based on RNA interference.—Cambridge-based ThingMagic, a maker of software and hardware for radio frequency identification (RFID) readers, was acquired by Sunnyvale, CA-based Trimble (NASDAQ: TRMB).—Resolvyx Pharmaceuticals of Cambridge sold private equity firm Celtic Therapeutics an option to acquire its lead drug, RX-10045, and license it as a treatment for eye conditions.
Classifications
AskAI Classifications
LabelsLinked Companies
